Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. - Wikidata - awgldk - TriplyDB

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

http://www.wikidata.org/entity/Q33819656

about

Nanostructures for the Inhibition of Viral Infections Anti-HIV-1 nanotherapeutics: promises and challenges for the future Macrophage derived cystatin B/cathepsin B in HIV replication and neuropathogenesis Achieving HIV-1 Control through RNA-Directed Gene Regulation Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials The Rules of Variation Expanded, Implications for the Research on Compatible Genomics Triple combination MPT vaginal microbicide using curcumin and efavirenz loaded lactoferrin nanoparticles Nanotechnology and HIV: potential applications for treatment and prevention.Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Nanostructured optical photonic crystal biosensor for HIV viral load measurement.Nucleic acid aptamers: clinical applications and promising new horizons Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation.Nanotechnology and the treatment of HIV infection.Antiretroviral Drugs-Loaded Nanoparticles Fabricated by Dispersion Polymerization with Potential for HIV/AIDS Treatment.pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection.Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS.The role of neuroplasticity and cognitive reserve in aging with HIV: recommendations for cognitive protection and rehabilitation.Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus.Immediate tangential excision accelerates wound closure but does not reduce scarring of mid-dermal porcine burns.Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?Achieving a cure for HIV infection: do we have reasons to be optimistic?A sight on the current nanoparticle-based gene delivery vectors.Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.Vaccine nanoparticles for protection against HIV infection.Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.Protein/peptide-based entry/fusion inhibitors as anti-HIV therapies: challenges and future direction.Label-Free Raman Hyperspectral Imaging of Single Cells Cultured on Polymer Substrates.Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.Improving combination antiretroviral therapy by targeting HIV-1 gene transcription.Smart nanoparticles as targeting platforms for HIV infections.Adjuvanticity and toxicity of cobalt oxide nanoparticles as an alternative vaccine adjuvant.Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.

P2860

Q26801513-18EDD6E9-A19D-461C-9FDA-5160AA22A268 Q26828464-8EC65B5A-0BE7-4367-B932-0EDDEED35F63 Q27024355-40C66A1E-C416-4EDA-B938-4FD29231E829 Q28080090-3863C1A4-A22B-4DEB-BF0F-53E9D9D55BFC Q28081272-D03A9677-CB30-4330-94E8-321CDB30844E Q28087336-D83B5429-0B8D-4FBD-92AA-01442AC81C5A Q28390117-311726B2-667F-4E28-A456-E07BB56EAF43 Q28393885-385D23B4-4B89-4680-8CE8-C95C99AC5800 Q30393980-FB85E4C7-DB70-4C3A-99BE-41BB50D2A323 Q30407161-B37BA52B-4640-4957-AADD-21B5A7CC6795 Q30431343-1076EF40-C8D7-4C22-8828-729F61FA9521 Q30442145-A01586F7-DE5E-4B33-85AF-D62646A3BBCD Q34028112-D94B9A5F-AFE2-44EA-A548-6C20ECF4A0D5 Q34784522-E6270147-8CC9-4B0A-91BB-09F9443D65F1 Q34801630-B18B38CA-8468-4679-97BC-8A446E50059B Q35943647-0E79C4C4-E810-4F2B-880C-4FCEE4E951DA Q35970023-84B6A823-B1DB-4C7D-A796-6D8787A8E842 Q36032459-8A6C1E52-AFF8-4443-98C3-5E81E427FD20 Q36284047-72CF7903-66BD-4EE7-BE58-CACB7212FEFC Q36338109-55E4BEAB-D44E-46BE-8997-26BDBD63A640 Q37013364-7578782E-35E7-4654-8C1E-3769E498CC9D Q37169223-EE5BEA70-4064-4E38-8D59-BDCE926326B5 Q37280337-F52A9F34-84C7-4A82-B6D0-1D47BA635FD5 Q37412296-A2D3FAEE-3249-420C-BAC0-E03B766E2A9F Q37867083-C6C62411-BA23-48CD-9043-DE8DF62AAD5D Q37980423-BC3D031A-5425-4BD1-9CD7-77B9B3CA8790 Q38220813-55F5E7A3-22C0-4E88-92C5-D53AA840AAAA Q38296086-A0DE2184-8D7B-49A8-8B10-81754BB20041 Q38405327-E31731A1-F7C4-4B59-AF7B-7F41FB405656 Q38495022-EC547DB5-5600-4AAD-849A-60F2F7112185 Q38574172-3B7C367A-9DCC-4DD5-8AEA-2A0301623419 Q38614638-6E148173-4BE9-4A1A-861C-5A29D681A2B6 Q38622404-B6223D33-4DD4-431C-9B43-B0DE57B721BD Q38761022-CCE2C504-C797-4DBC-BC95-FBE70161C647 Q38764703-A266032A-2BBA-4F97-92F0-A2C7A5C48E10 Q38856263-9A0457BB-F8EA-4898-B329-D53999B6A200 Q38887077-51CB72A1-778C-4155-AA87-52E8ACD8E8C3 Q39311895-E7E0F6D5-51EA-4E56-AF92-F4A0A8B3FF62 Q39527615-7BE2CEFD-5FAD-492D-8C00-6524A176BAC8 Q40105941-33F2ECE3-5D0B-4C1B-82C6-BDF297E5BBD8

P2860

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

http://www.wikidata.org/entity/Q33819656

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

@ast

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

@en

type

label

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

@ast

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

@en

prefLabel

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

@ast

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

@en

P1433

Q33819656-22E5968D-E980-44C5-9D7F-BDDEBDA839FC

P1476

Q33819656-5152515E-36AF-4DAF-8D5B-CE9D56957B92

P2093

Q33819656-5182679D-FEC0-40C8-B082-322F3390969B

Q33819656-52FFE390-D7AD-4959-9479-B914A01C4F9E

Q33819656-9C87A621-231F-4EAA-B6A8-43C8384002CC

Q33819656-A5BEF639-5D77-4BD7-BFB0-08F48B72F5A7

Q33819656-B19BC6EA-BC1A-4943-8AD2-96A5BD852CAC

Q33819656-B80022CD-F5A4-4583-9C52-CBF2F2971FE1

Q33819656-C8FA6E19-0EFC-48D7-B176-02765485CFDC

P2860

Q33819656-02DBC527-1451-4664-B059-7A50560DF4A9

Q33819656-037ADCF2-8864-4F78-BDC0-47599FCF44FB

Q33819656-0B70E23A-50AC-4F52-9A67-467172E2446E

Q33819656-0BF7380B-513E-41C0-83A3-88CCEFB56C08

Q33819656-0DA35DE9-0EE2-4157-BE5F-EB9BAA3DB030

Q33819656-0E4A533F-EDC1-4B5A-9D40-A9027EFA6B28

Q33819656-100DCC7F-57F5-436F-997E-0BB61F92E563

Q33819656-1068CB68-E737-4C2C-9D63-D4CC3B6ABEB3

Q33819656-11E835C6-E829-4510-B689-652B81075803

Q33819656-13BB9B2B-2846-4C76-BEAB-D490AFB2E43C

P304

Q33819656-A7F340B5-CD85-422F-A33C-2CBE601114AD

P31

Q33819656-7145AC27-CB3E-40EC-8A69-937CA17488E4

P356

Q33819656-6C7BBDBD-7D71-476A-A71A-C318196AB482

P433

Q33819656-E4490F82-5FB7-4C75-A77E-50E523868902

P478

Q33819656-B75A742F-D1FA-42BC-9C7F-26921BE865D2

P50

Q33819656-3B7922F0-8D59-463B-B882-22E8792A80EF

Q33819656-6983BDEE-701A-4E13-96EF-3FADD3A54965

P577

Q33819656-AC744FA8-8D8B-4F8C-B72C-6833D2CE87B9

P698

Q33819656-3B65578B-CC01-4C56-A6C9-68E87A515950

Q33819656-482eb568-1c10-414f-befd-d7673fe83c68

P921

Q33819656-19E5A319-2047-45BF-AB97-488599742A68

Q33819656-B213A097-AE46-4966-917C-58E2F2E9158F

Q33819656-B94FD114-AB0A-469D-A32F-5D44B8AE97A5

P932

Q33819656-43D72816-811A-4EC1-AFEC-FE41E5A7AF81

P356

P1433

P1476

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

@en

P2093

Carolina Salvador-Morales

http://www.w3.org/2001/XMLSchema#string

Daniel R Kuritzkes

http://www.w3.org/2001/XMLSchema#string

E Ashley Moseman

http://www.w3.org/2001/XMLSchema#string

Jinjun Shi

http://www.w3.org/2001/XMLSchema#string

Omid C Farokhzad

http://www.w3.org/2001/XMLSchema#string

Robert Langer

http://www.w3.org/2001/XMLSchema#string

Tewodros Mamo

http://www.w3.org/2001/XMLSchema#string

P2860

Antigen presentation and T cell stimulation by dendritic cells

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

Interaction of silver nanoparticles with HIV-1.

X-ray structures of the hexameric building block of the HIV capsid.

Toll-like receptors

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathology

Immunobiology of dendritic cells

Cancer nanotechnology: opportunities and challenges

Nanoparticle therapeutics: an emerging treatment modality for cancer

P304

269-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.10.1

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Nagesh Kolishetti

Ulrich von Andrian

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20148638

http://www.w3.org/2001/XMLSchema#string

P921

prevention of HIV/AIDS

P932

2861897

http://www.w3.org/2001/XMLSchema#string